LA JOLLA—Every day, your pancreas produces about one cup of digestive juices, a mixture of molecules that can break down the food you eat. But if these powerful molecules become activated before they make their […]
Unique, innovative and stable formula is critical in supporting the body’s detoxification process SAN DIEGO, April 21, 2022 /PRNewswire/ — Cymbiotika, a leading nutritional supplement brand known for creating pure, clinically backed supplements, today announced […]
SAN DIEGO–(BUSINESS WIRE)–n-Lorem received a $3 million donation to support its efforts in ASO research and discovery Click here to view original post
SAN DIEGO–(BUSINESS WIRE)–Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will report first quarter 2022 financial results on Wednesday, May 4, 2022, after the close of the U.S. financial markets. Acadia’s management team will […]
Peer-reviewed results from the two-level multi-center FDA Investigational Device Exemption study reiterate disc’s superiority to ACDF SAN DIEGO, April 21, 2022 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on […]
SAN DIEGO & BOSTON–(BUSINESS WIRE)–IQHQ, Inc., a leading and sustainable life sciences real estate development company, today announced the launch of its inaugural ESG Annual Report. Click here to view original post
ROTTERDAM, Netherlands and SAN DIEGO, April 21, 2022 /PRNewswire/ — Today, SkylineDx presents new data showing that their Merlin Test was able to prospectively reduce >37% of surgeries in a non-interventional study for newly diagnosed […]
LA JOLLA— Ursula Bellugi, Distinguished Professor Emerita and Founder’s Chair at the Salk Institute, 2008 inductee to the National Academy of Sciences and winner of the Jacob Javitz Neuroscience Investigator Award, died peacefully on April […]
Conference Call Scheduled for Wednesday, April 27 at 4:30 p.m. Eastern Time SAN DIEGO, April 20, 2022 /PRNewswire/ — Viking Therapeutics, Inc. (“Viking”) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel […]
SAN DIEGO, April 20, 2022 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today the Company will release its […]
SAN DIEGO, April 20, 2022 /PRNewswire/ — Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, will announce financial results for the first quarter of 2022 along with recent corporate updates on May 4, […]
Scientists at UC San Diego School of Medicine and Rady Children’s Institute of Genomic Medicine describe novel methods for inferring the movement of human brain cells during fetal development by studying healthy adult individuals who […]
Virtual event to take place on Wednesday, April 27, 2022, at 11:00 AM EDT SAN DIEGO, April 20, 2022 /PRNewswire/ — Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company targeting virus-associated malignancies, will host […]
Acquisition complements and expands Synergy’s surgical services to include anesthesia SAN DIEGO, April 20, 2022 /PRNewswire/ — Synergy Health Partners, a leading hospital services company that improves access to patient care through innovative and custom […]
SAN DIEGO–(BUSINESS WIRE)– #COVID19–Selva Announces Preclinical Data Confirming SLV213 Potently Inhibits Infection By the SARS-CoV-2 Omicron Variant Click here to view original post
SAN DIEGO , April 20, 2022 /PRNewswire/ — Engage Aesthetics, a division of Boise, Idaho based Engage Technologies Group, Inc., is proud to launch the first phase of their newest Aesthetics Library. This release of […]
SAN DIEGO–(BUSINESS WIRE)—- $ARCT #ClinicalTrial–Arcturus Announces Self-amplifying COVID-19 mRNA Vaccine Candidate ARCT-154 Meets Primary Efficacy Endpoint in Phase 3 Study Click here to view original post
Webcast scheduled for Wednesday, May 4 at 11:30 a.m. Eastern Time CARLSBAD, Calif., April 20, 2022 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that it will host a live webcast on Wednesday, May […]
SAN DIEGO, April 20, 2022 /PRNewswire/ — Phanes Therapeutics, Inc. (Phanes), an emerging leader in innovative discovery research and development in immuno-oncology, revealed that the company has completed the manufacturing scale production of a bispecific […]
For most of us, when we make major career choices, we tend to lean into what we’re good at. According to new findings from the University of California San Diego’s Rady School of Management, such […]
Experienced Sales Leader to Drive Global Adoption of Disruptive Products for Single Cell Genomics SAN DIEGO and CAMBRIDGE, England, April 19, 2022 /PRNewswire/ — CS Genetics, a privately held genomics-technology company, today announced the appointment […]
SAN DIEGO, April 19, 2022 /PRNewswire/ — Veterans have traditionally been prone to struggle with PTSD, substance addiction, and suicidal ideation. These challenges were exacerbated during the pandemic, during which many Veterans were isolated from […]
SAN MATEO, Calif.–(BUSINESS WIRE)–Clarion Partners Real Estate Income Fund Inc. (CPREIF) has strategically expanded its property portfolio with the acquisition of Fusion Life Science HQ*, a 121,541 square foot hybrid creative office and research and […]
Latest funding round is led by global investor B Capital and aims to help Carlsmed get its FDA approved and Medicare reimbursed personalized medicine technology to more hospitals and patients. Click here to view original […]
When Acadia Pharmaceuticals put down $52.5 million in cash to buy out CerSci Therapeutics – along with $887 million in biobucks – in 2020, CEO Steve Davis made clear that its non-opioid painkillers for acute […]
WALTHAM, Mass.–(BUSINESS WIRE)–Avilar Therapeutics, a biopharmaceutical company focused on extracellular protein degradation, today announced a scientific poster presentation highlighting ATACs (ASGPR-Targeting Chimeras) at the 5th annual Protein Degradation Using PROTACs & Molecular Glues meeting being […]
For a second year in a row, we’ve launched a 20 under 40 project and arrived, months later, with a list of 21 names. The reason for that is simple: No matter how much we […]
SAN DIEGO–(BUSINESS WIRE)–Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced top-line results from a Phase 2 randomized, double-blind, placebo-controlled clinical trial evaluating the efficacy and safety of ACP-044 for acute pain following bunionectomy surgery. The primary […]
UC San Diego Health announces the opening of a new, multi-disciplinary clinic for patients with gastrointestinal and digestive diseases. The state-of-the-art clinic is the first of its kind in San Diego County to offer the […]
The biotech bear market is not leaving medtech companies out of its reach, as Integrity Implants, aka Accelus, is now discovering. Accelus and SPAC partner CHP Merger Corp. will no longer be joining hands in […]
Copyright © 2022 Biotech Networks, LLC
